Form 4: HCA Director Hugh F. Johnston Receives Equity Award

Director Hugh F. Johnston acquired 809 restricted share units as part of his annual director compensation package.

Summary

• Director Hugh F. Johnston was granted 809 restricted share units (RSUs) on April 28, 2026.
• The grant consists of 509 RSUs as an annual director equity award and 300 RSUs in lieu of an annual cash retainer.
• The total beneficial ownership for the director following this transaction is 4,475 shares of common stock.
• The RSUs vest on the earlier of the 2027 annual shareholders' meeting or the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Director opted to receive a portion of his cash retainer in equity, demonstrating confidence in the company.

Negatives

• None identified.

Risks

• Vesting is contingent upon continued service as a member of the Board of Directors.

Future Outlook

The restricted share units are scheduled to vest on the date of the 2027 annual shareholders' meeting or the first anniversary of the grant date, whichever occurs first.

Industry Context

StockSavvy.ai notes that standard director compensation practices in the healthcare sector frequently involve a mix of cash retainers and equity grants to ensure long-term alignment with corporate performance.

Comparison to Industry Standards

• The use of restricted share units for director compensation is consistent with standard corporate governance practices for large-cap healthcare companies.
• The election to receive equity in lieu of cash is a common practice among board members of S&P 500 companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard director compensation event.

Next Steps

• Vesting of the 809 restricted share units in 2027.

Key Dates

Keywords

HCA Healthcare, Director Compensation, Equity Award, Insider Transaction, Form 4